Search

Search Constraints

You searched for: Author/Creator Bluthgen, Virginia

Search Results

1. Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations. (May 2022)

2. Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non–small cell lung cancer treated with immunotherapy. (March 2021)